Re: Update from IR -- Eversana paused?
in response to
by
posted on
Dec 22, 2022 10:11AM
Great post fuzzy.
koo – “Unless a major third partner happens to come on board ( 2 being EC and HL) I see no other way to get us on the way to BOM2.”
Koo, my guess for Eastern Capital is that RVX is out of sight and out of mind for Ken Dart (Dr Wong’s trusted ally). Based on my calculations Eastern did not even participate in casting their votes for the BOD at the last AGM and have not come to RVX with much needed funding. I do think it is possible that they may provide some sort of leverage for Don as we near the debenture deadline in the spring of 2023 with Hepa in order to protect their holdings. JMO.
fuzzy – “Imo Dm has single headedly destroyed this company. If he's fed bp the same bs he feeds others in private im sure they figured him out long ago & have all the patience in the world to slowly crush him & his ego in any sort of negotiation(s)it appears he is a one in million chump to them & they've played him like soft putty”.
Fuzzy, I agree with you completely. If BPs view Don (which as I have come too) as an incompetent, dishonest snake, then I think they’ll just let him sink until he has nothing to negotiate. Don is a pathetic case of the Peter Principle, sadly.
However, on the positive side at least at Zenith Epigenetics Dr Wong remains involved, with his seat on the BOD, and with Eastern having made a fairly recent investment to retain a strong share position. Dr Sanjay Lakhotia, a member of the team that Dr Cherrington had begun to build before her rather premature departure seems to be making rather brilliant progress in establishing partnerships with the NIH, NCI and numerous BPs. Dr Cherrington has continued her successful career in biotech.
My guess about Don is that he really likes playing the role of being a biotech big shot. His joint (RVX +ZCC) salary is $600,00 and he has the support of his BODs, which probably means his salary could bump too $800K next year and $1M after that, if the companies survive. Then he’ll be close to 70 and perhaps ready to retire. The salary increases would be justified by the Compensation Committee using the classic logic that "he deserved the rasies because he kept the company alive during stormy waters".
The best Christmas gift our Pied Piper could give RVX and ZCC shareholders is to resign his CEO positions immediately. Dr Lakhotia could take the CEO job at ZCC and the BOD could get on with a search for a new RVX CEO.
JMHO. I remain long. I've view this as a crap shoot. I'd prefer to view it as a well run business. Oh well. :)
Merry Christmas to all.
Cheers
Toinv